KLA stock sinks 5% in late-day slide; analysts lift targets ahead of Jan. 29 results
21 January 2026
1 min read

KLA stock sinks 5% in late-day slide; analysts lift targets ahead of Jan. 29 results

New York, Jan 20, 2026, 19:13 EST — After-hours

  • KLA shares dropped 5.2% in Tuesday’s regular trading, closing at $1,486.18
  • The decline occurred amid a widespread selloff across U.S. markets, accompanied by unusually high volume
  • Attention turns to KLA’s earnings report and outlook due Jan. 29

KLA Corp (KLAC.O) shares dropped 5.2% on Tuesday, then held steady in after-hours trading. The sharp decline put the chip-equipment maker behind some of its industry rivals. 1

KLA’s stock had been hitting new highs only days ago, making this drop significant as the company gears up to report quarterly results next week. In semiconductors, a slip this close to earnings can quickly shift investor positioning. 1

KLA, a major player in process-control equipment used to inspect and measure chips in production, is closely watched as a gauge of customer demand for advanced manufacturing. Attention now turns to its upcoming report on sales and profit margins. 2

Tuesday saw a rough session for U.S. stocks, with the S&P 500 dropping 2.06% and the Dow sliding 1.76%, per MarketWatch data. Applied Materials took a hit too, falling 2.68% that day. 1

KLA dipped to $1,484.53 during the session before closing at $1,486.18. Trading volume hit about 1.7 million shares, edging past its recent average, according to market data. 1

Even as the stock dipped, analyst notes rolled in. UBS’s Timothy Arcuri maintained a hold rating but raised his price target sharply—from $1,260 to $1,635, according to 5 .

Needham bumped its price target up to $1,800 from $1,350, maintaining a “Strong Buy” rating, TipRanks reported. 3

KLA announced earlier this month it will release its fiscal second-quarter 2026 results on Jan. 29, after the U.S. market closes. A conference call is scheduled for 2 p.m. Pacific (5 p.m. Eastern). 2

KLA continues to flag uncertainty around policy and demand in China, a market it has identified as occasionally weaker. 4

Investors are keeping an eye on wafer-fab equipment—the gear behind chip production—after a solid rally pushed valuations to levels that could get tight if the market shifts.

The stock closed Tuesday roughly 6% under its 52-week peak from Jan. 16, despite a surge that brought it close to all-time highs earlier this month. 1

The regular trading day won’t resume until Jan. 21, leaving Jan. 29 as the next key date: KLA’s earnings report, and, crucially, its forecast for the upcoming quarter. 2

Stock Market Today

SAP stock price: Treasury stake tops 5% as buyback focus builds into next week

SAP stock price: Treasury stake tops 5% as buyback focus builds into next week

7 February 2026
FRANKFURT, Feb 7, 2026, 22:33 CET — Market closed. SAP SE shares ended Friday at 171.22 euros on Xetra, up 0.43%, as investors digested a disclosure that the software group’s holding of its own stock has moved above the 5% line. 1 With European markets shut for the weekend, the filing matters less for what it “changes” on paper and more for what it signals about supply and demand when trading resumes on Monday. Treasury shares are stock a company holds in itself; when that pile grows, the number of shares in the market shrinks. SAP’s stock has been searching
L’Oreal share price slips into weekend as OR.PA heads for annual results test

L’Oreal share price slips into weekend as OR.PA heads for annual results test

7 February 2026
L’Oréal shares closed at 394.05 euros in Paris on Friday, down 0.16%, marking a second straight session of losses. The company will release its 2025 annual results after markets close on Feb. 12, with a financial meeting set for Feb. 13. About 319,000 shares traded Friday in a range between 385.70 and 395.10 euros. The STOXX 600 rose 0.9% to 617.12 points.
Corvus Pharmaceuticals stock surges 167% on eczema drug data as $150 million offering kicks off
Previous Story

Corvus Pharmaceuticals stock surges 167% on eczema drug data as $150 million offering kicks off

3M stock price drops after outlook miss, with tariffs and 2026 demand back in focus
Next Story

3M stock price drops after outlook miss, with tariffs and 2026 demand back in focus

Go toTop